Immunome IMNM
NASDAQ IMNM
$21.89 0.00 (-0.01%)
As of: Sep 30, 2026 · 10:25 AM EDT

Immunome (IMNM) Receivables - Other (2022 - 2023)

Updated

Immunome (IMNM) posted Receivables - Other of $208,000 for Q2 2023, down 98.8% from $17.4 million a year earlier and down 74.7% from the prior quarter.

Analysis

Immunome (IMNM) Receivables - Other (2022 - 2023) Analysis & Trends

At the end of FY2022, Immunome's Receivables - Other came in at $847,000, up 323.5% from FY2021.

  • In prior years, Immunome's Receivables - Other was $200,000 in FY2021.
  • The Q2 2023 figure stands as the lowest quarterly Receivables - Other since Q1 2022.
  • According to Business Quant data, Receivables - Other for the three prior quarters was $821,000 (Q1 2023), $847,000 (Q4 2022) and $847,000 (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Immunome 2.46 Bn 429.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 208,000.00
Mar 31, 2023 821,000.00
Dec 31, 2022 847,000.00
Sep 30, 2022 847,000.00
Jun 30, 2022 17.40 Mn
Mar 31, 2022 200,000.00
API Access

Immunome Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=IMNM&period=max&api_key=YOUR_API_KEY